CRBP
Corbus Pharmaceuticals Holdings, Inc. · Healthcare
Cormorant Asset Management, LP bought $14.3M of Corbus Pharmaceuticals Holdings, Inc.
10% owner
Bought$14,250,000
$19.00Price
750,000Shares
+103%Stake
What CRBP did for a copier
- $1,000 copied at Wed, Feb 7 open, $26.70
- $1,429
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Mar 21 close.
Cormorant Asset Management, LP's record
16 other buys with 3 months of prices since 2016: on average −9.8% against the S&P 500, and 7 of 16 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 2. Filed Tue, Feb 6, 4:00 PM ET, after the close. Returns use the Feb 7 open and the Mar 21 close. Not investment advice.